Publications

Avelumab Expanded Access Program in Metastatic Merkel Cell Carcinoma: Efficacy and Safety Findings from Patients in Europe and the Middle East

AuthID
P-00V-ADV

Author(s)

Ascierto, PA

Orlova, K

Grignani, G

Dudzisz Sledz, M

Fenig, E

Sileni, VC

Fazio, N

Samimi, M

Mortier, L

Gebhardt, C

Kramkimel, N

Steven, N

Bechter, O

Arance, A

Benincasa, E

Kostkova, L

Costa, N

Lorigan, P

Document Type

Article in Press

Year published

2021

Published

in INTERNATIONAL JOURNAL OF CANCER, ISSN: 0020-7136

Volume: 149, Issue: 11, Pages: 1926-1934 (9)

Indexing

Wos^®

Scopus^®

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1002/ijc.33746

Pubmed: 34310716

Scopus: 2-s2.0-85116458545

Wos: WOS:000680507100001

Source Identifiers

ISSN: 0020-7136

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Avelumab Expanded Access Program in Metastatic Merkel Cell Carcinoma: Efficacy and Safety Findings from Patients in Europe and the Middle East

Useful Links

Get Help

Federated Authentication (Click on the image)

Avelumab Expanded Access Program in Metastatic Merkel Cell Carcinoma: Efficacy and Safety Findings from Patients in Europe and the Middle East

Useful Links

Get Help